Challenges of Implementation of the National Phenylketonuria Screening Program in Iran
A Qualitative Study
Keywords:
Challenges, Phenylketonuria, Screening, IranAbstract
Introduction: Newborn screening (NBS) is a public health measure aimed at identification of early cases, management of afflicted infants, and making efforts to reduce the morbidity and mortality among newborns. All countries may face challenges in implementation of screening programs. The present study aimed to determine the challenges of implementation of the National Phenylketonuria (PKU) Screening Program in Iran.
Methods: In this qualitative study, 38 health policymakers, managers, and PKU experts in Iran were purposively selected as the respondents in 2015. The semi-structured interview was used for collecting the required data and information. After transcription of interviews, their content was analyzed using framework analysis.
Results: The results were categorized into five main themes and 22 subthemes. The main themes extracted from data were management challenges, diagnosis challenges, treatment challenges, care challenges, and patients’ family problems. Each category consisted of several subthemes.
Conclusion: Considering the challenges of implementing this program, some measures such as increased stability of managers in the health system, greater interaction of the Ministry of Health and Medical Education with the heath stakeholders, improving the level of parents’ awareness, the use of efficient information systems, support and legal backing for requiring parents who refuse newborn screening for various reasons, and appropriate insurance coverage seem necessary to be taken.
References
Banta-Wright SA, Kodadek SM, Steiner RD, Houck GM. Challenges to breastfeeding infants with
phenylketonuria. J Pediatr Nurs. 2015; 30(1): 219-26. doi: 10.1016/j.pedn.2014.05.003. PMID: 24952998.
Soleymani Z, Keramati N, Rohani F, Jalaei S. Factors Influencing Verbal Intelligence and Spoken
Language in Children with Phenylketonuria. Indian Pediatr. 2015; 52(5): 397-401. doi: 10.1007/s13312- 015-0644-8. PMID: 26061925.
Mei L, Song P, Xu L. Newborn screening and related policy against Phenylketonuria in China. Intractable
Rare Dis Res. 2013; 2(3): 72-6. doi: 10.5582/irdr.2013.v2.3.72. PMID: 25343107, PMCID: PMC4204551.
Groselj U, Tansek MZ, Smon A, Angelkova N, Anton D, Baric I, et al. Newborn screening in southeastern
Europe. Mol Genet Metab. 2014; 113(1-2): 42-5. doi: 10.1016/j.ymgme.2014.07.020. PMID: 25174966.
Padilla CD, Krotoski D, Therrell BL Jr. Newborn screening progress in developing countries--overcoming
internal barriers. Semin Perinatol. 2010; 34(2): 145-55. doi: 10.1053/j.semperi.2009.12.007. PMID:
Groselj U, Tansek MZ, Battelino T. Fifty years of phenylketonuria newborn screening - A great success for
many, but what about the rest? Mol Genet Metab. 2014; 113(1-2): 8-10. doi:
1016/j.ymgme.2014.07.019. PMID: 25174964.
Karamifar H, Ordoei M, Karamizadeh Z, Amirhakimi GH. Incidence of neonatal hyperphenylalaninemia in
Fars province, South Iran. Iran J Pediatr. 2010; 20(2): 216-20. PMID: 23056707, PMCID: PMC3446017.
Asadollah H, Falahzadeh MH, Kazerouni HR, Ganj Karimi AH. Incidence of phenylketonuria in southern
Iran. Iran J Basic Med Sci. 2010; 35(2): 137-9.
Aghasi P, Setoodeh A, Sayarifard A, Rashidiyan M, Sayarifard F, Rabbani A, et al. Intellectual and
Developmental Status in Children With Hyperphenylalaninemia and PKU Who Were Screened in a
National Program. Iran J Pediatr. 2015; 25(6): 3033. doi: 10.5812/ijp.3033. PMID: 26635939, PMCID:
PMC4662839.
Elbualy M, Bold A, De Silva V, Gibbons U. Congenital hypothyroid screening: the Oman experience. J
Trop Pediatr. 1998; 44(2): 81-3. PMID: 9604594.
Dhondt JL, Farriaux JP, Sailly JC, Lebrun T. Economic evaluation of cost-benefit ratio of neonatal
screening procedure for phenylketonuria and hypothyroidism. J Inherit Metab Dis. 1991; 14(4): 633-9.
PMID: 1749228.
Ben Romdhane H, Tlili F, Skhiri A, Zaman S, Phillimore P. Health system challenges of NCDs in Tunisia.
Int J Public Health. 2015; 60(1): 39-46. doi: 10.1007/s00038-014-0616-0. PMID: 25399240.
Moshiri E. Using policy analysis methods and heuristic generalization approaches to provide a rich
understanding of the mismatch between development of the referral system and the development of the
PHC network in Iran's health care system: Identifying appropriate policy making theories [PhD Thesis]:
Tehran University of medical sciences. 2015; 242.
Ozalp I, Coşkun T, Tokatli A, Kalkanoglu HS, Dursun A, Tokol S, et al. Newborn PKU screening in
Turkey: at present and organization for future. Turk J Pediatr. 2000; 43(2): 97-101. PMID: 11432505.
Han YJ, Lee DH. Measures to Improve Newborn Screening System in Korea. Available from:
https://www.kihasa.re.kr/common/filedown.do?seq=33013
Rashidiyan A. Policy challenges and the need to create coherent structures to help the evidence base
decision making on health system. Hakim Res J. 2013; 16(3): 258-61.
Kalisch BJ, Lee H, Salas E. The development and testing of the nursing teamwork survey. Nurs Res. 2010;
(1): 42-50. doi: 10.1097/NNR.0b013e3181c3bd42. PMID: 20010044.
Salas E, Diaz Granados D, Weaver SJ, King H. Does team training work? Principles for health care. Acad
Emerg Med. 2008; 15(11): 1002-9. doi:10.1111/j.1553-2712.2008.00254. PMID: 18828828.
Chakraborti C, Boonyasai RT, Wright SM, Kern DE. A systematic review of teamwork training
interventions in medical student and resident education. J Gen Intern Med. 2008; 23(6): 846-53. doi:
1007/s11606-008-0600-6. PMID: 18386100, PMCID: PMC2517885.
Padilla CD, Therrell BL. Newborn screening in the Asia Pacific region. J Inherit Metab Dis. 2007; 30(4):
-506. doi: 10.1007/s10545-007-0687-7. PMID: 17643195.
Mei L, Song P, Xu L. Newborn screening and related policy against Phenylketonuria in China. Intractable
Rare Dis Res. 2013; 2(3): 72-6. doi: 10.5582/irdr.2013.v2.3.72. PMID: 25343107, PMCID: PMC4204551.
Borrajo GJ. Newborn screening in Latin America at the beginning of the 21st century. J Inherit Metab Dis.
; 30(4): 466-81. doi: 10.1007/s10545-007-0669-9. PMID: 17701285.
Han YJ, Lee DH, Kim JW. Newborn screening in Korea. Southeast Asian J Trop Med Public Health. 2003;
(3): 81-4. PMID: 15906703.
Aye R, Wyss K, Abdualimova H, Saidaliev S. Illness costs to households are a key barrier to access
diagnostic and treatment services for tuberculosis in Tajikistan. BMC Res Notes. 2010; 3(1): 340. doi:
1186/1756-0500-3-340. PMID: 21172015, PMCID: PMC3022814.
Van Doorslaer E, O'Donnell O, Rannan-Eliya RP, Somanathan A, Adhikari SR, Garg CC, et al. Effect of
payments for health care on poverty estimates in 11 countries in Asia: an analysis of household survey data.
Lancet. 2006; 368(9544): 1357-64. doi: 10.1016/S0140-6736(06)69560-3. PMID: 17046468.
Russell S. The economic burden of illness for households in developing countries: a review of studies
focusing on malaria, tuberculosis, and human immunodeficiency virus/acquired immunodeficiency
syndrome. Am J Trop Med Hyg. 2004; 71(2): 147-55. PMID: 15331831.
Kazemiyan M, Javadi Nasab H. Socio-economic Determinants of Health Expenditure for Low-income
Households in the Informal Sector. J Kerman Univ Med Sci. 2014; 21(2): 151-61.
Huang MC, Lee CK, Lin SJ, Lu IC. Parental consent for newborn screening in southern Taiwan. J Med
Ethics. 2005; 31(11): 621-4. doi: 10.1136/jme.2004.010074. PMID: 16269553, PMCID: PMC1734047.
Campbell E, Ross LF. Parental attitudes regarding newborn screening of PKU and DMD. Am J Med Genet
A. 2003; 120(2): 209-14. doi: 10.1002/ajmg.a.20031. PMID: 12833401.
Alberta Health and Wellness, Community and Population Health Division Alberta Newborn Metabolic
Screening Program Policy Document. 2010. Available from:
http://www.health.alberta.ca/documents/Newborn-Metabolic-Screening-Policy-2010.pdf
Negar M, Badiee Aval S, Hosseini Yazdi SMR, Norouzi F, Mina T. The Epidemiological and Clinical
Study of Phenylketonuria (PKU) Patients in Khorasan, North-eastern Iran. IJN. 2015; 6(1): 18-22.
Eshraghi P, Abaskhanian A, Mohammadhasani and A. Characteristics of patients with phenylketonuria in
Mazandaran Province, northern, Iran. Caspian J Intern Med. 2010; 1(2): 72-4.
Vela-Amieva M, Ibarra-González I, Fernández-Lainez C, Monroy-Santoyo S, Guillén-López S, Belmont- Martinez L, et al. Causes of delay in referral of patients with phenylketonuria to a specialized reference
center in Mexico. J Med Screen. 2011; 18(3): 115-20. doi: 10.1258/jms.2011.011028. PMID: 22045819.
Stranieri I, Takano OA. Evaluation of the Neonatal Screening Program for congenital hypothyroidism and
phenylketonuria in the State of Mato Grosso, Brazil. Arq Bras Endocrinol Metabol. 2009; 53(4): 446-52.
doi: 10.1258/jms.2011.011028. PMID: 19649383.
Adesa AE, Walkera J, Jonesb R, Smithc I. Coverage of neonatal screening: failure of coverage or failure of
information system. Arch Dis Child. 2001; 84(6): 476-9. doi:10.1136/adc.84.6.476.
Tomasi E, Facchini LA, Maia MF. Health information technology in primary health care in developing
countries: a literature review. Bull World Health Organ. 2004; 82(11): 867-74. PMID: 15640923, PMCID:
PMC2623061.
Mirkhalafzadeh M, Haddadpoor A, Mazroei F, Nasri M, Bahrami G. Designing and Developing a Software
for Hypothyroidism and Phenylketonuria Screening in Newborns. J Mazandaran Univ Med Sci. 2014;
(120): 148-9.
Published
Issue
Section
License
Copyright (c) 2020 KNOWLEDGE KINGDOM PUBLISHING
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
